Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
•
Male Breast Cancer
Is it reasonable to use hypofractionation in early stage male breast cancer s/p lumpectomy?
What clinical and pathologic features - if any - would necessitate conventional fractionation?
Answer from: Radiation Oncologist at Community Practice
Absolutely the same as what we do for women with breast cancer.
Comments
Radiation Oncologist at Allegheny Health Network, Pittsburgh
Agreed, while we don't have an RCT for male breast...
Radiation Oncologist at SSM Cancer Center/St Louis CyberKnife
Taking this question further, can we assume that p...
6090
15916
Sign in or Register to read more
12580
Related Questions
How would you approach surveillance imaging for men with early-stage, hormone receptor-positive breast cancer after unilateral mastectomy?
Given the 10-year outcomes of UK FAST-Forward presented at ESTRO, how have you expanded the use of ultra-hypofractionation in your practice?
How would you manage a pT2N1a invasive ductal carcinoma s/p lumpectomy and sentinel lymph node biopsy with ECE, and two mildly avid axillary lymph nodes on post-op PET/CT?
How do you manage symptomatic fat necrosis following adjuvant breast radiotherapy?
For patients between 40-49 years old who undergo lumpectomy, how do you choose between offering PBI per the updated PBI guidelines or boosting based on boost guidelines?
Does pre-chemotherapy extent of nodal involvement impact your decision to offer adjuvant radiation in cN1, ypN0 triple-negative breast cancer?
Would you offer prone APBI with IMRT/VMAT?
Is there additional concern for late cardiac toxicity when using ultrahypofractionated breast radiation protocols, given that the BED to the heart is higher?
Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?
Would you offer ultrahypofractionated 5-fraction whole breast only for a women with ER-/HER2+/cN+ disease with pCR following neoadjuvant systemic therapy?
Agreed, while we don't have an RCT for male breast...
Taking this question further, can we assume that p...